Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Genesys International Corporation Limited (NSE: GENESYS), ISIN INE727B01026 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
GENESYS last traded at ₹297.00 (+5.64%), with a 52-week range of ₹135.41 to ₹418.17 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 31.50%, FIIs 1.53%, DIIs 1.12%, mutual funds 0.00%.
EquiSense Score (ECS): 69/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.